Home > Publications > miR-181a mediates TGF-b induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer.

miR-181a mediates TGF-b induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer.

This paper identifies a miR that replaces TGFb in inducing EMT and is now a candidate for HCC therapy.

Brockhausen J, Vadas MA, Gamble JR, McCaughan GW.

LiverInt 2015; 35:240-53

Date: 2015